Showing 8791-8800 of 23044 results for "".
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
https://reachmd.com/programs/medical-industry-feature/research-uncovers-a-potential-biomarker-for-postpartum-depression-risk/29924/A novel study identifies a possible biomarker in progesterone metabolism that may help assess postpartum depression risk.The World’s Smallest Heart Pump
https://reachmd.com/programs/clinicians-roundtable/the-worlds-smallest-heart-pump/3367/Dr. Michael Siegenthaler, associate professor of surgery at the University of Pittsburgh School of Medicine, describes the Impella 2.5 system: a percutaneously-placed ventricular-assist device, now approved for high risk coronary interventions, that has earned the moniker, 'world's smallest heart puTransforming Wound Care: Sensor-Based Dressings and Novel Therapeutics in Healing
https://reachmd.com/programs/clinicians-roundtable/transforming-wound-care-sensor-based-dressings-and-novel-therapeutics-in-healing/36431/Sensor-based dressings and small-molecule therapeutics represent a new era in wound care, enabling earlier infection detection and more effective treatment of chronic wounds. Dr. Geoffrey Gurtner discusses how these emerging technologies could address a critical unmet need, aiming to prevent complicSCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. James Q. Del Rosso on Innovative Therapies
https://practicaldermatology.com/error/404/James Q. Del Rosso, DO, joins Joel Cohen, MD, to discuss innovation in the world of acne and rosacea, atopic dermatitis, psoriasis, alopecia areata, hidradenitis suppurativa, vitiligo, and more at Music City SCALE.Tolerability of JAK Inhibitors Used in Dermatology
https://practicaldermatology.com/series/jak-inhibitors-in-practice/tolerability-of-jak-inhibitors-used-in-dermatology/20126/Although safety and tolerability are often intertwined, they are distinct considerations. Topical and oral JAKs used in dermatology today seem to offer good tolerability. Adelaide A. Hebert, MD and Matthew Zirwas, MD discuss potential side effects, management, and monitoring in pediatric and adult pPlot Your Presentation Path in 5 Steps
https://reachmd.com/programs/speaking-of/plot-your-presentation-path-five-steps/10105/Learn how to organize your content easily and effectively.Safer Choices in Contraception for Women With Severe Heart Disease
https://reachmd.com/programs/advances-in-womens-health/safer-choices-in-contraception-for-women-with-severe-heart-disease/3329/For women with severe cardiac disease, pregnancy is not advisable due to significant risks of maternal and fetal morbidity and mortality. Dr. Lisa Mazzullo talks with Dr. Abimbola Famuyide, principle investigator in a recent study on hysteroscopic steriization at the Mayo Clinic in Rochester, MinnesVagus Nerve Stimulation: Effects Beyond the Nervous System
https://reachmd.com/programs/practical-neurology/vagus-nerve-stimulation-effects-beyond-the-nervous-system/30101/Stavros Zanos, MD, PhD, Associate Professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, uses neurostimulation as a means to study the nervous system and to treat diseases in which the nervous system is affected or implicated. In this episode, Dr. Zanos gives an oProgressing Towards Post-ERCP Pancreatitis Prevention
https://reachmd.com/programs/gi-insights/progressing-towards-post-ercp-pancreatitis-prevention/16593/What are the risk factors associated with post-ERCP pancreatitis, and how can we prevent this complication in our patients?Bringing Telemedicine into Primary Care
https://reachmd.com/programs/primary-care-today/bringing-telemedicine-primary-care/7501/From patient consultation services to remote physician visits, telemedicine is rapidly gaining a foothold in clincial practice. But what are the potential gains vs pitfalls for integrating these technologies at the primary care level? Dr. Mark Seraly, practicing dermatologist and founder of Dermatol